These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12855141)

  • 1. [Ecstasy-induced fulminant hepatic failure and emergency liver transplantation].
    Carrión JA; Escorsell A; Nogué S; Mas A
    Med Clin (Barc); 2003 Jun; 121(3):118-9. PubMed ID: 12855141
    [No Abstract]   [Full Text] [Related]  

  • 2. Liver transplantation for ecstasy-induced fulminant hepatic failure.
    De Carlis L; De Gasperi A; Slim AO; Giacomoni A; Corti A; Mazza E; Di Benedetto F; Lauterio A; Arcieri K; Maione G; Rondinara GF; Forti D
    Transplant Proc; 2001 Aug; 33(5):2743-4. PubMed ID: 11498145
    [No Abstract]   [Full Text] [Related]  

  • 3. Ecstasy ingestion and fulminant hepatic failure: liver transplantation to be considered as a last therapeutic option.
    Garbino J; Henry JA; Mentha G; Romand JA
    Vet Hum Toxicol; 2001 Apr; 43(2):99-102. PubMed ID: 11308131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ecstasy induced acute hepatic failure. Case reports.
    Atayan Y; Çağın YF; Erdoğan MA; Harputluoglu MM; Bilgic Y
    Acta Gastroenterol Belg; 2015; 78(1):53-5. PubMed ID: 26118578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe chronic hepatitis secondary to prolonged use of ecstasy and cocaine.
    Payancé A; Scotto B; Perarnau JM; de Muret A; Bacq Y
    Clin Res Hepatol Gastroenterol; 2013 Nov; 37(5):e109-13. PubMed ID: 23910059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ecstasy-induced brain death and acute hepatocellular failure: multiorgan donor and liver transplantation.
    Caballero F; Lopez-Navidad A; Cotorruelo J; Txoperena G
    Transplantation; 2002 Aug; 74(4):532-7. PubMed ID: 12352914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute hepatitis due to ecstasy].
    Roques V; Perney P; Beaufort P; Hanslik B; Ramos J; Durand L; Le Bricquir Y; Blanc F
    Presse Med; 1998 Mar; 27(10):468-70. PubMed ID: 9767974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Auxiliary liver transplantation for acute liver failure after intake of 3,4-methylenedioxymethamphetamine ("Ecstasy")].
    Hellinger A; Rauen U; de Groot H; Erhard J
    Dtsch Med Wochenschr; 1997 May; 122(22):716-20. PubMed ID: 9213536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is a dose of ecstasy?
    Cole JC; Sumnall HR; Wagstaff GF
    J Psychopharmacol; 2002 Jun; 16(2):189-90. PubMed ID: 12095080
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ecstasy is a dangerous drug the society chooses to ignore].
    Heilig M
    Lakartidningen; 2003 Feb; 100(9):688-90. PubMed ID: 12674555
    [No Abstract]   [Full Text] [Related]  

  • 11. Valvular heart disease in a patient taking 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy').
    Montastruc F; Montastruc G; Vigreux P; Bruneval P; Guilbeau-Frugier C; Cron C; Bagheri H; Delisle B; Lapeyre-Mestre M; Pathak A; Montastruc JL
    Br J Clin Pharmacol; 2012 Sep; 74(3):547-8. PubMed ID: 22364182
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; "Ecstasy").
    Cohen RS
    Biol Psychiatry; 1996 May; 39(9):819-20. PubMed ID: 8731525
    [No Abstract]   [Full Text] [Related]  

  • 13. [A woman with swollen lips].
    Naisas H; Zaszlos KJ
    Ned Tijdschr Geneeskd; 2015; 159():A8665. PubMed ID: 26154747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fulminant Budd-Chiari syndrome due to ecstasy.
    Taş A; Kara B; Yılmaz C; Suat Yalçın M; Dilek O; Olmez S; Saritas B
    Clin Res Hepatol Gastroenterol; 2017 Feb; 41(1):e12-e13. PubMed ID: 27459877
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurological and psychopathological sequelae associated with a lifetime intake of 40,000 ecstasy tablets.
    Kouimtsidis C; Schifano F; Sharp T; Ford L; Robinson J; Magee C
    Psychosomatics; 2006; 47(1):86-7. PubMed ID: 16384814
    [No Abstract]   [Full Text] [Related]  

  • 16. Selective neurocognitive deficits associated with multiple doses of ecstasy/MDMA: a reply to Cole.
    Fox HC; Parrott AC
    J Psychopharmacol; 2003 Jun; 17(2):242-4. PubMed ID: 12870575
    [No Abstract]   [Full Text] [Related]  

  • 17. 3,4-Methylenedioxymethamphetamine (ecstasy)-induced hepatotoxicity: multidetector CT and pathology findings.
    Lawler LP; Abraham S; Fishman EK
    J Comput Assist Tomogr; 2001; 25(4):649-52. PubMed ID: 11473199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reality of psychomotor problems, and the possibility of Parkinson's disorder, in some recreational ecstasy/MDMA users: a rejoinder to Sumnall et al. (2003).
    Parrott AC; Rodgers J; Buchanan T; Scholey AB; Heffernan T; Ling J
    Psychopharmacology (Berl); 2004 Jan; 171(2):231-3. PubMed ID: 14634710
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute myelopathy selectively involving lumbar anterior horns following intranasal insufflation of ecstasy and heroin.
    Riva N; Morana P; Cerri F; Gerevini S; Amadio S; Formaglio F; Comi G; Comola M; Del Carro U
    J Neurol Neurosurg Psychiatry; 2007 Aug; 78(8):908-9. PubMed ID: 17635986
    [No Abstract]   [Full Text] [Related]  

  • 20. Airway Necrosis and Barotrauma after Ecstasy Inhalation.
    Van den Kerckhove E; Roosens L; Siozopoulou V; Verbrugghe W; Aerts J; Huyskens J; Raemen H; Jorens PG
    Am J Respir Crit Care Med; 2017 Jul; 196(1):105-106. PubMed ID: 28288287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.